A recent study sheds light on independent influences of risks and benefits when patients with multiple sclerosis (MS) make hypothetical treatment decisions. Furthermore, researchers examine how individual differences in this probability discounting function are associated with patient demographics, clinical characteristics, disease knowledge, neuropsychiatric status, and adherence. 208 participants with relapsing-remitting MS indicated their likelihood (0–100%) of taking a hypothetical medication as the probability of mild side effects (11 values from .1 to 99.9%) and reported medication efficacies (11 values from .1 to 99.9%) varied systematically. They also completed a series of questionnaires and cognitive tests. Researchers found:
- Individual components of medication treatment decision making were successfully described with a probability discounting model.
- High rates of discounting based on risks were associated with poor treatment adherence and less disease-specific knowledge.
- In contrast, high rates of discounting of benefits was associated with poorer cognitive functioning.
- Regression models indicated that risk discounting predicted unique variance in treatment adherence.
Bruce JM, Bruce AS, Lynch S, et al. Probability discounting of treatment decisions in multiple sclerosis: Associations with disease knowledge, neuropsychiatric status, and adherence. [Published online ahead of print September 22, 2018]. Psychopharmacology. doi:10.1007/s00213-018-5037-y.
This Week's Must Reads
Stroke Care Comparison of Asian Americans and Whites, JAMA Neurology; ePub 2019 Jan 22; Song, Liang, et al
Aerobic Exercise Can Improve Executive Functioning , Neurology; 2019 Jan 15; Blumenthal, et al
Episodic Memory Decline is Neurodegenerative Marker, Neurology; ePub 2019 Jan 23; Wilson, Yang, et al
Serum Troponin Level Marker for Visceral Infarcts , J Stroke Cerebrovasc Dis; ePub 2019 Jan 18; Azher, et al
Urine Sodium-to-Potassium Ratio Predicts Stroke, Stroke; ePub 2019 Jan 21; Averill, Young, et al
Must Reads in Multiple Sclerosis
Prevalence of Asthma in Persons with MS, Mult Scler Relat Disord; ePub 2018 Dec 11; Hill, et al
Normal-Appearing White Matter in MS Examined, Neuroradiology; ePub 2018 Dec 12; Yu, et al
MS Disease Burden: Which Symptoms Matter Most?, Mult Scler Relat Disord; 2018 Oct; Barin, et al
Retinal Layer Thickness and MS Conversion Risk, Mult Scler; ePub 2018 Dec 3; Filippatou, et al
Importance of Coping and QOL in People with MS, Int J MS Care; ePub 2018 Dec 6; Grech, et al